Postchemoradiotherapy Neutrophil-to-Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers

<div>Comparative survival outcomes per posttreatment neutrophil-to-lymphocyte ratio. (a) Overall survival and (b) distant metastasis-free survival.</div>

International Journal of Clinical Practice

fig2

Figure 2

Figure 2: Postchemoradiotherapy Neutrophil-to-Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers 

Figure 2 | Postchemoradiotherapy Neutrophil-to-Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers 